# A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer

> **NCT06710314** · — · ENROLLING_BY_INVITATION · sponsor: **Dong Peng** · enrollment: 150 (estimated)

## Conditions studied

- Metabolomics

## Interventions

- **DIAGNOSTIC_TEST:** Colorectal cancer patients with hypertension
- **DIAGNOSTIC_TEST:** Colorectal cancer patients with diabetes
- **DIAGNOSTIC_TEST:** Colorectal cancer patients with fatty liver

## Key facts

- **NCT ID:** NCT06710314
- **Lead sponsor:** Dong Peng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-07-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710314, "A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome Radical Resection of Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06710314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*